The Sovereign States Drug Consortium (SSDC) is a collaborative group of Medicaid states. Collectively members are focused on providing quality pharmaceutical care while controlling costs.
The primary activity of the SSDC is a Medicaid drug rebate program that negotiates for rebates that are in addition to those required under the federal Medicaid Drug Rebate Program. The SSDC also provides a forum for Member States to cooperate in other areas of pharmacy benefit administration and management in Medicaid and other publicly funded pharmacy benefit programs. One such project is a diabetic supply rebate program.
Change Healthcare is the SSDC’s current supplemental rebate negotiator and has managed the SSDC negotiation process since 2006. For more information on Change Healthcare , see www.changehealthcare.com.
For more information about the SSDC and its programs and activities, see: